Taken together, the maintenance of strong LRRC8A expression may be conducted by the drug stimulation, suggesting that LRRC8A may be an important factor in the acquisition of oxaliplatin resistance for colon cancer cells. Here, LRRC8A is linked to malignant colon neoplasm.